Registration summary
ConferenceICAVB
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.
Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDG-Aligned Research Themes
ICAVB conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.
01 Mechanisms of Atherosclerosis +
This track will explore the underlying biological mechanisms driving atherosclerosis, including lipid accumulation and inflammatory responses. Emphasis will be placed on novel insights into cellular and molecular pathways that contribute to plaque formation and progression.
02 Vascular Biology and Endothelial Function +
This session will focus on the role of endothelial cells in vascular health and disease, highlighting their function in maintaining vascular homeostasis. Discussions will include the impact of endothelial dysfunction on cardiovascular outcomes and potential therapeutic strategies.
03 Lipid Metabolism and Cardiovascular Risk +
This track will examine the relationship between lipid metabolism and cardiovascular disease, emphasizing the role of dyslipidemia in atherosclerosis. Research on novel lipid-lowering therapies and their implications for clinical practice will also be presented.
04 Vascular Inflammation in Cardiovascular Disease +
This session will investigate the role of inflammation in the pathogenesis of cardiovascular diseases, particularly focusing on atherosclerosis. Presentations will cover both basic research and clinical studies that elucidate inflammatory pathways as therapeutic targets.
05 Coronary Artery Disease: Advances in Diagnosis and Treatment +
This track will highlight recent advancements in the diagnosis and management of coronary artery disease, including imaging techniques and interventional strategies. The session aims to foster discussions on personalized medicine approaches in treating this prevalent condition.
06 Innovations in Cardiovascular Research +
This session will showcase cutting-edge research methodologies and technologies in cardiovascular science, including genomics, proteomics, and bioinformatics. Participants will have the opportunity to discuss how these innovations can enhance our understanding of cardiovascular diseases.
07 Heart Disease in Special Populations +
This track will address the unique challenges and considerations in diagnosing and managing heart disease in special populations, such as women, the elderly, and individuals with comorbidities. Emphasis will be placed on tailored approaches to improve outcomes in these groups.
08 Translational Research in Atherosclerosis +
This session will focus on the translation of basic research findings into clinical applications for atherosclerosis management. Discussions will include successful case studies and the challenges faced in bridging the gap between laboratory and clinical settings.
09 Lifestyle Interventions and Cardiovascular Health +
This track will explore the impact of lifestyle factors, such as diet, exercise, and smoking cessation, on cardiovascular health and disease prevention. Evidence-based strategies for promoting heart-healthy behaviors will be discussed.
10 Emerging Therapies in Cardiovascular Medicine +
This session will highlight novel therapeutic approaches for cardiovascular diseases, including pharmacological agents and innovative interventional techniques. The potential of gene therapy and regenerative medicine in treating heart disease will also be explored.
11 Global Perspectives on Cardiovascular Disease +
This track will provide insights into the global burden of cardiovascular disease, examining disparities in prevalence, treatment, and outcomes across different populations. Discussions will focus on public health strategies and policies aimed at reducing cardiovascular morbidity and mortality worldwide.
